Sandra Chambonnet

Title: Innovations by Sandra Chambonnet in Pharmaceutical Development

Introduction

Sandra Chambonnet is a notable inventor based in Paris, France. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of leishmaniasis. With a total of two patents to her name, her work has the potential to impact the medical community positively.

Latest Patents

Sandra's latest patents include innovative formulations and associations for the treatment of leishmaniasis. The first patent focuses on dronedarone or its pharmaceutically acceptable salts for this purpose. The second patent details a pharmaceutical composition for oral administration that contains dronedarone, aimed at minimizing the meal time effect following oral intake. This composition utilizes a lipid carrier to enhance the solubility of the active ingredient and protect it from the adverse effects of pH in the intestinal tract.

Career Highlights

Sandra Chambonnet is currently associated with Sanofi, a leading global healthcare company. Her work at Sanofi has allowed her to explore and develop innovative solutions in the pharmaceutical sector.

Collaborations

Throughout her career, Sandra has collaborated with esteemed colleagues such as Stephane Beilles and Jean-Pierre Collaveri. These collaborations have further enriched her research and development efforts.

Conclusion

Sandra Chambonnet's contributions to pharmaceutical innovations, particularly in the treatment of leishmaniasis, highlight her role as a significant inventor in the field. Her work continues to pave the way for advancements in medical treatments.